Skip to main content

Molecular Control of Development in Normal and Leukemic Myeloid Cells by Cytokines, Tumor Suppressor and Oncogenes

  • Conference paper
Book cover Molecular Aspects of Myeloid Stem Cell Development

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 211))

Abstract

The establishment of a cell culture system for the clonal development of hematopoietic cells made it possible to discover the proteins that regulate cell viability, multiplication and differentiation of different hematopoietic cell lineages and the molecular basis of normal and abnormal development in blood-forming tissues (reviewed in [1–5]). These regulators include cytokines now called colony stimulating factors (CSFs) and interleukins (ILs) and hematopoiesis is controlled by a network of cytokine interactions [1–7]. This multigene network includes positive regulators such as CSFs and ILs and negative regulators such as transforming growth factor β and tumor necrosis factor. The cytokine network which has arisen during evolution allows considerable flexibility depending on which part of the network is activated and the ready amplification of response to a particular stimulus. Hematopoietic cytokines can induce the expression of transcription factors [8]. Cytokine signalling through transcription factors can thus ensure the autoregulation and transregulation of cytokine genes that occur in the network.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sachs L (1987) The molecular control of blood cell development. Science 238:1374–1379

    Article  PubMed  CAS  Google Scholar 

  2. Sachs L (1990) The control of growth and differentiation in normal and leukemic blood cells. The 1989 Alfred P Sloan Prize of the General Motors Cancer Research Foundation. Cancer 65:2196–2206

    Google Scholar 

  3. Sachs L (1992) The molecular control of hematopoiesis: From clonal development in culture to therapy in the clinic. Int J Cell Cloning 10:196–204

    Article  PubMed  CAS  Google Scholar 

  4. Sachs L (1993) The molecular control of hemopoiesis and leukemia. CR Acad Sci Paris, Sciences de la vie 316:882–891

    Google Scholar 

  5. Sachs L (1995) The adventures of a biologist: Prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis and tumor suppression. Foundations in Cancer Research. Advances Cancer Research 66:1–40

    Article  CAS  Google Scholar 

  6. Lotem J, Shabo Y, Sachs L (1991) The network of hematopoietic regulatory proteins in myeloid cell differentiation. Cell Growth Differ 2:421–427

    PubMed  CAS  Google Scholar 

  7. Blatt C, Lotem J, Sachs, L (1992) Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene. Cell Growth Differ 3:671–676

    PubMed  CAS  Google Scholar 

  8. Shabo Y, Lotem J, Sachs L (1990) Induction of genes for transcription factors by normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells. Leukemia 4:797–801

    PubMed  CAS  Google Scholar 

  9. Lotem J, Cragoe EJ, Sachs L (1991) Rescue from programmed cell death in leukemic and normal myelpid cells. Blood 78:953–960

    PubMed  CAS  Google Scholar 

  10. Lotem J, Sachs L (1992) Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80:1750–1757

    PubMed  CAS  Google Scholar 

  11. Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82:15–21

    PubMed  CAS  Google Scholar 

  12. Sachs L, Lotem, J (1995) Apoptosis in the hemopoietic system. In: Gregory CD (ed) Apoptosis and the Immune Response. Wiley, New York, pp 371–403

    Google Scholar 

  13. Lotem J, Sachs L (1995) Interferon-γ inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells. Leukemia 9:685–692

    PubMed  CAS  Google Scholar 

  14. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin 6. Nature 352:345–347

    Article  PubMed  CAS  Google Scholar 

  15. Lotem J, Sachs L (1993) Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ 4:41–47

    PubMed  CAS  Google Scholar 

  16. Lotem J, Sachs L (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82:1092–1096

    PubMed  CAS  Google Scholar 

  17. Lotem J, Sachs L (1994) Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ 5:321–327

    PubMed  CAS  Google Scholar 

  18. Lotem J, Sachs L (1995) Regulation of bcl-2, bcl-XLand bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 6:647–653

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Sachs, L. (1996). Molecular Control of Development in Normal and Leukemic Myeloid Cells by Cytokines, Tumor Suppressor and Oncogenes. In: Wolff, L., Perkins, A.S. (eds) Molecular Aspects of Myeloid Stem Cell Development. Current Topics in Microbiology and Immunology, vol 211. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85232-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85232-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85234-3

  • Online ISBN: 978-3-642-85232-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics